NADINE KAKANOU: Open Payments
NPI 1063044279 · BURTONSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 8 payments from 7 companies in 2025. Trend: 2023 $101 · 2024 $106 · 2025 $191
Food & beverage: $191
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 1 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, INGREZZA, REXULTI, ABILIFY MAINTENA, Auvelity, ARISTADA.
Industry payments across MD — which companies pay providers there.
